Eye injection burden: which patients struggle most?
NCT ID NCT07514559
First seen Apr 13, 2026 · Last updated May 06, 2026 · Updated 5 times
Summary
This study looked at how much of a burden patients feel from repeated eye injections (anti-VEGF) for three different eye diseases: wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Researchers interviewed 393 patients about their treatment burden, socioeconomic status, and demographics. The goal was to find factors that affect how well patients stick with their treatment, which can help doctors improve care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION (ARMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hietzing Hospital
Vienna, 1130, Austria
Conditions
Explore the condition pages connected to this study.